ACCADRINE (AC262) SARM IN CAPSULES

AC-262536 (Accadrine) — research SARM

AC-262536 (accadrine) is a selective androgen receptor modulator studied for a partial-agonist profile — of interest to researchers exploring receptor selectivity and comparatively mild activity within the SARM class. That nuanced profile is part of its research appeal. HelixaMed supplies AC-262536 independently assayed for identity and concentration.

Less common compounds are exactly where unverified product proliferates, so third-party testing matters most here — a certificate of analysis confirms each capsule matches its label. As with the wider category, hormonal pathways can be affected, so post-cycle support planning is sensible. Sold strictly as a research compound; no dosing or human-use guidance is provided.

• Partial-agonist profile: studied for receptor selectivity.
• Verified: identity and concentration lab-checked.
• Considered use: plan recovery as with any SARM protocol.